[1]
Alempijevic T, Zec S, Milosavljevic T. Drug-induced liver injury: Do we know everything? World journal of hepatology. 2017 Apr 8:9(10):491-502. doi: 10.4254/wjh.v9.i10.491. Epub
[PubMed PMID: 28443154]
[2]
Holt M, Ju C. Drug-induced liver injury. Handbook of experimental pharmacology. 2010:(196):3-27. doi: 10.1007/978-3-642-00663-0_1. Epub
[PubMed PMID: 20020257]
[3]
Yu YC, Mao YM, Chen CW, Chen JJ, Chen J, Cong WM, Ding Y, Duan ZP, Fu QC, Guo XY, Hu P, Hu XQ, Jia JD, Lai RT, Li DL, Liu YX, Lu LG, Ma SW, Ma X, Nan YM, Ren H, Shen T, Wang H, Wang JY, Wang TL, Wang XJ, Wei L, Xie Q, Xie W, Yang CQ, Yang DL, Yu YY, Zeng MD, Zhang L, Zhao XY, Zhuang H, Drug-induced Liver Injury (DILI) Study Group, Chinese Society of Hepatology (CSH), Chinese Medical Association (CMA). CSH guidelines for the diagnosis and treatment of drug-induced liver injury. Hepatology international. 2017 May:11(3):221-241. doi: 10.1007/s12072-017-9793-2. Epub 2017 Apr 12
[PubMed PMID: 28405790]
[4]
Holubek WJ, Kalman S, Hoffman RS. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology (Baltimore, Md.). 2006 Apr:43(4):880; author reply 882
[PubMed PMID: 16557558]
[5]
Galan MV, Potts JA, Silverman AL, Gordon SC. The burden of acute nonfulminant drug-induced hepatitis in a United States tertiary referral center [corrected]. Journal of clinical gastroenterology. 2005 Jan:39(1):64-7
[PubMed PMID: 15599214]
[6]
Andrade RJ, Lucena MI, Fernández MC, Pelaez G, Pachkoria K, García-Ruiz E, García-Muñoz B, González-Grande R, Pizarro A, Durán JA, Jiménez M, Rodrigo L, Romero-Gomez M, Navarro JM, Planas R, Costa J, Borras A, Soler A, Salmerón J, Martin-Vivaldi R, Spanish Group for the Study of Drug-Induced Liver Disease. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology. 2005 Aug:129(2):512-21
[PubMed PMID: 16083708]
[7]
Bunchorntavakul C, Reddy KR. Review article: herbal and dietary supplement hepatotoxicity. Alimentary pharmacology & therapeutics. 2013 Jan:37(1):3-17. doi: 10.1111/apt.12109. Epub 2012 Nov 5
[PubMed PMID: 23121117]
[8]
Ye H, Nelson LJ, Gómez Del Moral M, Martínez-Naves E, Cubero FJ. Dissecting the molecular pathophysiology of drug-induced liver injury. World journal of gastroenterology. 2018 Apr 7:24(13):1373-1385. doi: 10.3748/wjg.v24.i13.1373. Epub
[PubMed PMID: 29632419]
[9]
Aleo MD, Luo Y, Swiss R, Bonin PD, Potter DM, Will Y. Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump. Hepatology (Baltimore, Md.). 2014 Sep:60(3):1015-22. doi: 10.1002/hep.27206. Epub 2014 Jul 14
[PubMed PMID: 24799086]
[10]
Larrey D. Epidemiology and individual susceptibility to adverse drug reactions affecting the liver. Seminars in liver disease. 2002:22(2):145-55
[PubMed PMID: 12016546]
[11]
Devarbhavi H. An Update on Drug-induced Liver Injury. Journal of clinical and experimental hepatology. 2012 Sep:2(3):247-59. doi: 10.1016/j.jceh.2012.05.002. Epub 2012 Sep 21
[PubMed PMID: 25755441]
[12]
Tajiri K, Shimizu Y. Practical guidelines for diagnosis and early management of drug-induced liver injury. World journal of gastroenterology. 2008 Nov 28:14(44):6774-85
[PubMed PMID: 19058303]
[13]
Chalasani NP, Hayashi PH, Bonkovsky HL, Navarro VJ, Lee WM, Fontana RJ, Practice Parameters Committee of the American College of Gastroenterology. ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. The American journal of gastroenterology. 2014 Jul:109(7):950-66; quiz 967. doi: 10.1038/ajg.2014.131. Epub 2014 Jun 17
[PubMed PMID: 24935270]
[14]
Yamashita YI, Imai K, Mima K, Nakagawa S, Hashimoto D, Chikamoto A, Baba H. Idiosyncratic drug-induced liver injury: A short review. Hepatology communications. 2017 Aug:1(6):494-500. doi: 10.1002/hep4.1064. Epub 2017 Jun 28
[PubMed PMID: 29404475]
[15]
Pauli-Magnus C, Meier PJ. Hepatobiliary transporters and drug-induced cholestasis. Hepatology (Baltimore, Md.). 2006 Oct:44(4):778-87
[PubMed PMID: 17006912]
[16]
Zhang X, Ouyang J, Thung SN. Histopathologic manifestations of drug-induced hepatotoxicity. Clinics in liver disease. 2013 Nov:17(4):547-64, vii-viii. doi: 10.1016/j.cld.2013.07.004. Epub 2013 Sep 4
[PubMed PMID: 24099017]
[17]
García Rodríguez LA, Ruigómez A, Jick H. A review of epidemiologic research on drug-induced acute liver injury using the general practice research data base in the United Kingdom. Pharmacotherapy. 1997 Jul-Aug:17(4):721-8
[PubMed PMID: 9250549]
[18]
Katarey D, Verma S. Drug-induced liver injury. Clinical medicine (London, England). 2016 Dec:16(Suppl 6):s104-s109
[PubMed PMID: 27956449]
[19]
Aithal GP, Watkins PB, Andrade RJ, Larrey D, Molokhia M, Takikawa H, Hunt CM, Wilke RA, Avigan M, Kaplowitz N, Bjornsson E, Daly AK. Case definition and phenotype standardization in drug-induced liver injury. Clinical pharmacology and therapeutics. 2011 Jun:89(6):806-15. doi: 10.1038/clpt.2011.58. Epub 2011 May 4
[PubMed PMID: 21544079]
Level 3 (low-level) evidence
[20]
Gayam V, Khalid M, Shrestha B, Hossain MR, Dahal S, Garlapati P, Gill A, Mandal AK, Sangha R. Drug-Induced Liver Injury: An Institutional Case Series and Review of Literature. Journal of investigative medicine high impact case reports. 2018 Jan-Dec:6():2324709618761754. doi: 10.1177/2324709618761754. Epub 2018 Mar 14
[PubMed PMID: 29568780]
Level 2 (mid-level) evidence
[21]
Lee WM, Hynan LS, Rossaro L, Fontana RJ, Stravitz RT, Larson AM, Davern TJ 2nd, Murray NG, McCashland T, Reisch JS, Robuck PR, Acute Liver Failure Study Group. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology. 2009 Sep:137(3):856-64, 864.e1. doi: 10.1053/j.gastro.2009.06.006. Epub 2009 Jun 12
[PubMed PMID: 19524577]
[22]
Giannattasio A, D'Ambrosi M, Volpicelli M, Iorio R. Steroid therapy for a case of severe drug-induced cholestasis. The Annals of pharmacotherapy. 2006 Jun:40(6):1196-9
[PubMed PMID: 16720710]
Level 3 (low-level) evidence
[23]
Enjalbert F, Rapior S, Nouguier-Soulé J, Guillon S, Amouroux N, Cabot C. Treatment of amatoxin poisoning: 20-year retrospective analysis. Journal of toxicology. Clinical toxicology. 2002:40(6):715-57
[PubMed PMID: 12475187]
Level 2 (mid-level) evidence
[24]
Degott C, Feldmann G, Larrey D, Durand-Schneider AM, Grange D, Machayekhi JP, Moreau A, Potet F, Benhamou JP. Drug-induced prolonged cholestasis in adults: a histological semiquantitative study demonstrating progressive ductopenia. Hepatology (Baltimore, Md.). 1992 Feb:15(2):244-51
[PubMed PMID: 1735527]
[25]
Björnsson E, Olsson R. Outcome and prognostic markers in severe drug-induced liver disease. Hepatology (Baltimore, Md.). 2005 Aug:42(2):481-9
[PubMed PMID: 16025496]
[26]
Andrade RJ, Lucena MI, Kaplowitz N, García-Muņoz B, Borraz Y, Pachkoria K, García-Cortés M, Fernández MC, Pelaez G, Rodrigo L, Durán JA, Costa J, Planas R, Barriocanal A, Guarner C, Romero-Gomez M, Muņoz-Yagüe T, Salmerón J, Hidalgo R. Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry. Hepatology (Baltimore, Md.). 2006 Dec:44(6):1581-8
[PubMed PMID: 17133470]